Skip to content
10-Q

Quarterly Report

OPIANT PHARMACEUTICALS, INC.

0001385508-22-000131

← back to feed
Filed
Nov 14, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2022 · Nov 10, 2022 5.17M sh
Shares Diluted Q3 2022 · Sep 30, 2022 5.14M sh
Shares Diluted Q3 2022 · Sep 30, 2022 5.08M sh
Shares Diluted Q3 2022 · Sep 30, 2021 6.07M sh
Shares Diluted Q3 2022 · Sep 30, 2021 5.57M sh
Capex Q3 2022 · Sep 30, 2022 $418.96K
Capex Q3 2022 · Sep 30, 2021 $0
Operating Cash Flow Q3 2022 · Sep 30, 2022 −$17.47M
Operating Cash Flow Q3 2022 · Sep 30, 2021 −$77.06K
Long Term Debt Q3 2022 · Sep 30, 2022 $12.32M
Long Term Debt Q3 2022 · Dec 31, 2021 $16.07M
Cash And Equivalents Q3 2022 · Sep 30, 2022 $35.38M
Cash And Equivalents Q3 2022 · Dec 31, 2021 $37.85M
Stockholders Equity Q3 2022 · Sep 30, 2022 $20.5M
Stockholders Equity Q3 2022 · Jun 30, 2022 $29.6M
Stockholders Equity Q3 2022 · Mar 31, 2022 $39.26M
Stockholders Equity Q3 2022 · Dec 31, 2021 $46.84M
Stockholders Equity Q3 2022 · Sep 30, 2021 $42.01M
Stockholders Equity Q3 2022 · Jun 30, 2021 $36.36M
Stockholders Equity Q3 2022 · Mar 31, 2021 $33.99M
Stockholders Equity Q3 2022 · Dec 31, 2020 $35.49M
Current Liabilities Q3 2022 · Sep 30, 2022 $7.04M
Current Liabilities Q3 2022 · Dec 31, 2021 $6.85M
Total Liabilities Q3 2022 · Sep 30, 2022 $21.45M
Total Liabilities Q3 2022 · Dec 31, 2021 $23.59M
Current Assets Q3 2022 · Sep 30, 2022 $38.55M
Current Assets Q3 2022 · Dec 31, 2021 $69.16M
Total Assets Q3 2022 · Sep 30, 2022 $41.95M
Total Assets Q3 2022 · Dec 31, 2021 $70.43M
Eps Diluted Q3 2022 · Sep 30, 2022 −$1.93
Eps Diluted Q3 2022 · Sep 30, 2022 −$6.66
Eps Diluted Q3 2022 · Sep 30, 2021 $0.56
Eps Diluted Q3 2022 · Sep 30, 2021 $0.41
Eps Basic Q3 2022 · Sep 30, 2022 −$1.93
Eps Basic Q3 2022 · Sep 30, 2022 −$6.66
Eps Basic Q3 2022 · Sep 30, 2021 $0.77
Eps Basic Q3 2022 · Sep 30, 2021 $0.52
Sga Expense Q3 2022 · Sep 30, 2022 $3.07M
Sga Expense Q3 2022 · Sep 30, 2022 $11.42M
Sga Expense Q3 2022 · Sep 30, 2021 $3.38M
Sga Expense Q3 2022 · Sep 30, 2021 $8.76M
Rd Expense Q3 2022 · Sep 30, 2022 $4.13M
Rd Expense Q3 2022 · Sep 30, 2022 $20.87M
Rd Expense Q3 2022 · Sep 30, 2021 $4.88M
Rd Expense Q3 2022 · Sep 30, 2021 $12.12M
Net Income Q3 2022 · Sep 30, 2022 −$9.92M
Net Income Q3 2022 · Sep 30, 2022 −$33.84M
Net Income Q3 2022 · Jun 30, 2022 −$11.74M
Net Income Q3 2022 · Mar 31, 2022 −$12.19M
Net Income Q3 2022 · Sep 30, 2021 $3.42M
Net Income Q3 2022 · Sep 30, 2021 $2.26M
Net Income Q3 2022 · Jun 30, 2021 $1.68M
Net Income Q3 2022 · Mar 31, 2021 −$2.84M
Operating Income Q3 2022 · Sep 30, 2022 −$9.63M
Operating Income Q3 2022 · Sep 30, 2022 −$32.78M
Operating Income Q3 2022 · Sep 30, 2021 $3.96M
Operating Income Q3 2022 · Sep 30, 2021 $3.88M
Revenue Q3 2022 · Sep 30, 2022 $173.87K
Revenue Q3 2022 · Sep 30, 2022 $8.54M
Revenue Q3 2022 · Sep 30, 2021 $16.34M
Revenue Q3 2022 · Sep 30, 2021 $33.99M